{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Telmisartan+40+mg", "query": { "intervention": "Telmisartan 40 mg" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 11, "total_pages": 2, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Telmisartan+40+mg&page=2&page_size=10", "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-09-22T04:31:13.026Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT04360551", "title": "Pilot Clinical Trial of the Safety and Efficacy of Telmisartan for the Mitigation of Pulmonary and Cardiac Complications in COVID-19 Patients", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "COVID-19" ], "interventions": [ { "name": "Telmisartan 40mg", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of Hawaii", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 24, "start_date": "2020-07-01", "completion_date": "2022-04-26", "has_results": true, "last_update_posted_date": "2023-08-21", "last_synced_at": "2026-09-22T04:31:13.026Z", "location_count": 1, "location_summary": "Honolulu, Hawaii", "locations": [ { "city": "Honolulu", "state": "Hawaii" } ], "official_url": "https://clinicaltrials.gov/study/NCT04360551" }, { "nct_id": "NCT04518293", "title": "Efficacy and Safety of GMRx2 Compared to Dual Combinations for the Treatment of Hypertension", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Hypertension" ], "interventions": [ { "name": "Telmisartan 20 mg/amlodipine 2.5 mg/indapamide 1.25 mg", "type": "DRUG" }, { "name": "telmisartan 40 mg/amlodipine 5 mg/indapamide 2.5 mg", "type": "DRUG" }, { "name": "Telmisartan 20 mg/amlodipine 2.5 mg", "type": "DRUG" }, { "name": "telmisartan 40 mg/amlodipine 5 mg", "type": "DRUG" }, { "name": "Telmisartan 20 mg/indapamide 1.25 mg", "type": "DRUG" }, { "name": "telmisartan 40 mg/indapamide 2.5 mg", "type": "DRUG" }, { "name": "Amlodipine 2.5 mg/indapamide 1.25 mg", "type": "DRUG" }, { "name": "amlodipine 5 mg/indapamide 2.5 mg", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "George Medicines PTY Limited", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 1385, "start_date": "2021-07-09", "completion_date": "2023-09-01", "has_results": true, "last_update_posted_date": "2025-06-03", "last_synced_at": "2026-09-22T04:31:13.026Z", "location_count": 31, "location_summary": "Phoenix, Arizona • Scottsdale, Arizona • Tucson, Arizona + 24 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Scottsdale", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" }, { "city": "South Gate", "state": "California" }, { "city": "Tarzana", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT04518293" }, { "nct_id": "NCT00274599", "title": "PROBE Investigation of the Safety & Efficacy of Telmisartan (Micardis®) vs Ramipril (Altace®) Using ABPM in HTN", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Hypertension" ], "interventions": [ { "name": "Telmisartan", "type": "DRUG" }, { "name": "Ramipril", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Boehringer Ingelheim", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "19 Years", "maximum_age": null, "sex": "ALL", "summary": "19 Years and older" }, "enrollment_count": 812, "start_date": "2002-10-09", "completion_date": null, "has_results": false, "last_update_posted_date": "2023-12-06", "last_synced_at": "2026-09-22T04:31:13.026Z", "location_count": 43, "location_summary": "Birmingham, Alabama • Phoenix, Arizona • Tucson, Arizona + 40 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Long Beach", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00274599" }, { "nct_id": "NCT02593110", "title": "Telmisartan Plus Exercise to Improve Functioning in Peripheral Artery Disease", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Peripheral Artery Disease" ], "interventions": [ { "name": "Supervised Treadmill Exercise Therapy", "type": "BEHAVIORAL" }, { "name": "Telmisartan", "type": "DRUG" }, { "name": "\"No exercise\" control group", "type": "OTHER" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "BEHAVIORAL", "DRUG", "OTHER" ], "sponsor": "Northwestern University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 114, "start_date": "2016-01-04", "completion_date": "2022-06-15", "has_results": true, "last_update_posted_date": "2023-01-11", "last_synced_at": "2026-09-22T04:31:13.026Z", "location_count": 3, "location_summary": "Chicago, Illinois • New Orleans, Louisiana", "locations": [ { "city": "Chicago", "state": "Illinois" }, { "city": "New Orleans", "state": "Louisiana" }, { "city": "New Orleans", "state": "Louisiana" } ], "official_url": "https://clinicaltrials.gov/study/NCT02593110" }, { "nct_id": "NCT00281580", "title": "Telmisartan (Micardis) and Amlodipine (Norvasc) - Factorial Design Study for the Treatment of Hypertension", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Hypertension" ], "interventions": [ { "name": "Amlodipine 5 mg", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" }, { "name": "Telmisartan 20 mg", "type": "DRUG" }, { "name": "Telmisartan 40 mg", "type": "DRUG" }, { "name": "Amlodipine 10 mg", "type": "DRUG" }, { "name": "Telmisartan 80 mg", "type": "DRUG" }, { "name": "Amlodipine 2.5 mg", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Boehringer Ingelheim", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 1461, "start_date": "2006-04", "completion_date": null, "has_results": true, "last_update_posted_date": "2014-03-27", "last_synced_at": "2026-09-22T04:31:13.026Z", "location_count": 101, "location_summary": "Fairhope, Alabama • Huntsville, Alabama • Chandler, Arizona + 81 more", "locations": [ { "city": "Fairhope", "state": "Alabama" }, { "city": "Huntsville", "state": "Alabama" }, { "city": "Huntsville", "state": "Alabama" }, { "city": "Huntsville", "state": "Alabama" }, { "city": "Chandler", "state": "Arizona" } ], "official_url": "https://clinicaltrials.gov/study/NCT00281580" }, { "nct_id": "NCT01928927", "title": "Telmisartan to Reduce AIDS-Related Fibrotic and Inflammatory Contributors (TRAFIC Study)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "HIV-1 Infection" ], "interventions": [ { "name": "Telmisartan", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections", "sponsor_class": "NETWORK", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 58, "start_date": "2014-01", "completion_date": "2016-03", "has_results": true, "last_update_posted_date": "2021-08-03", "last_synced_at": "2026-09-22T04:31:13.026Z", "location_count": 11, "location_summary": "Los Angeles, California • Aurora, Colorado • Boston, Massachusetts + 8 more", "locations": [ { "city": "Los Angeles", "state": "California" }, { "city": "Aurora", "state": "Colorado" }, { "city": "Boston", "state": "Massachusetts" }, { "city": "St Louis", "state": "Missouri" }, { "city": "Rochester", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT01928927" }, { "nct_id": "NCT06815497", "title": "Telmisartan in Combination With Cytotoxic Regimens in Platinum-Resistant Ovarian Cancer", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Ovarian Cancer" ], "interventions": [ { "name": "Telmisartan", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Tyler J Curiel", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "FEMALE", "summary": "18 Years and older · Female only" }, "enrollment_count": 33, "start_date": "2026-01-21", "completion_date": "2029-05-14", "has_results": false, "last_update_posted_date": "2026-01-28", "last_synced_at": "2026-09-22T04:31:13.026Z", "location_count": 2, "location_summary": "Lebanon, New Hampshire • Manchester, New Hampshire", "locations": [ { "city": "Lebanon", "state": "New Hampshire" }, { "city": "Manchester", "state": "New Hampshire" } ], "official_url": "https://clinicaltrials.gov/study/NCT06815497" }, { "nct_id": "NCT03319823", "title": "Treating Nocturnal Hypertension and Nocturia in African American Men", "overall_status": "WITHDRAWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "High Blood Pressure" ], "interventions": [ { "name": "Thiazide Treatment Group", "type": "DRUG" }, { "name": "Intensified Thiazide Treatment Group", "type": "DRUG" }, { "name": "Combination Medication Treatment Group", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Cedars-Sinai Medical Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "35 Years", "maximum_age": "59 Years", "sex": "MALE", "summary": "35 Years to 59 Years · Male only" }, "enrollment_count": 0, "start_date": "2017-10-25", "completion_date": "2021-02-01", "has_results": false, "last_update_posted_date": "2021-02-04", "last_synced_at": "2026-09-22T04:31:13.026Z", "location_count": 1, "location_summary": "Los Angeles, California", "locations": [ { "city": "Los Angeles", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT03319823" }, { "nct_id": "NCT00274638", "title": "PROBE Parallel 6-week Treatment Comparing Telmisartan/Hydrochlorothiazide (HCT) (40/12.5 or 80/12.5) With Losartan/HCT (50/12.5) Using Ambulatory Blood Pressure Monitoring (ABPM)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Hypertension" ], "interventions": [ { "name": "Telmisartan & Hydrochlorothiazide", "type": "DRUG" }, { "name": "Losartan & Hydrochlorothiazide", "type": "DRUG" }, { "name": "ABPM", "type": "PROCEDURE" } ], "intervention_types": [ "DRUG", "PROCEDURE" ], "sponsor": "Boehringer Ingelheim", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 805, "start_date": "2002-07", "completion_date": null, "has_results": false, "last_update_posted_date": "2013-12-09", "last_synced_at": "2026-09-22T04:31:13.026Z", "location_count": 69, "location_summary": "Huntsville, Alabama • Little Rock, Arkansas • Carmichael, California + 57 more", "locations": [ { "city": "Huntsville", "state": "Alabama" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Carmichael", "state": "California" }, { "city": "Concord", "state": "California" }, { "city": "Fresno", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00274638" }, { "nct_id": "NCT04715763", "title": "INvestigating TELmisartin Study", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Covid19" ], "interventions": [ { "name": "Telmisartan Oral Product", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of Hawaii", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 24, "start_date": "2021-09-01", "completion_date": "2022-04-26", "has_results": false, "last_update_posted_date": "2022-07-01", "last_synced_at": "2026-09-22T04:31:13.026Z", "location_count": 1, "location_summary": "Honolulu, Hawaii", "locations": [ { "city": "Honolulu", "state": "Hawaii" } ], "official_url": "https://clinicaltrials.gov/study/NCT04715763" } ] }